Drug Profile
Research programme: neonatal barrier therapeutics - Ceragenix
Alternative Names: NeoCeramLatest Information Update: 07 May 2010
Price :
$50
*
At a glance
- Originator Ceragenix Pharmaceuticals
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Suspended Skin disorders
Most Recent Events
- 07 May 2010 Suspended - Preclinical for Skin disorders in USA (Topical)
- 22 May 2008 Preclinical trials in Skin disorders in USA (Topical)